Literature DB >> 28492584

[Community pharmacy; towards a new model.]

Teresa Spadea1, Paola Brusa2, Roberto Gnavi1, Massimo Mana3, Mario Giaccone4, Giuseppe Costa5.   

Abstract

In recent years, even in Italy, a new model of "Community pharmacy" is being developed, which identifies the pharmacist as the most accessible health care professional for citizens, and recognizes his role in preventing chronic diseases. A project started in Piedmont (Italy) in 2012 has aimed at applying and evaluating this model of pharmacy in the prevention of diabetes, through the early detection of individuals with undiagnosed diabetes or at high risk of developing the disease, or with counselling to diabetic patients not adhering to the optimal therapeutic pathway. The results suggest that the pharmacy might be able to implement an effective preventive action, particularly among socio-economically disadvantaged people, thereby helping to reduce inequalities in care. The cost/effectiveness evaluation of long-term outcomes, based on the use of existing health information systems, will provide more accurate information on the value of the model.

Entities:  

Mesh:

Year:  2017        PMID: 28492584     DOI: 10.1701/2681.27451

Source DB:  PubMed          Journal:  Recenti Prog Med        ISSN: 0034-1193


  3 in total

1.  Assessment of Non-Adherence to Oral Metformin and Atorvastatin Therapies: A Cross-Sectional Survey in Piedmont (Italy).

Authors:  Marco Parente; Irene Pignata; Roberto Gnavi; Teresa Spadea; Mirko Di Martino; Francesca Baratta; Paola Brusa
Journal:  Patient Prefer Adherence       Date:  2020-02-14       Impact factor: 2.711

2.  Opportunistic screening for type 2 diabetes in community pharmacies. Results from a region-wide experience in Italy.

Authors:  Roberto Gnavi; Veronica Sciannameo; Francesca Baratta; Cecilia Scarinzi; Marco Parente; Massimo Mana; Mario Giaccone; Paolo Cavallo Perin; Giuseppe Costa; Teresa Spadea; Paola Brusa
Journal:  PLoS One       Date:  2020-03-18       Impact factor: 3.240

3.  The patient burden of opioid-induced constipation: New insights from a large, multinational survey in five European countries.

Authors:  Viola Andresen; Vivek Banerji; Genevieve Hall; Amir Lass; Anton V Emmanuel
Journal:  United European Gastroenterol J       Date:  2018-07-13       Impact factor: 4.623

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.